Effects of Continuous Training on the Induction of Atrial Fibrillation in a Rabbit Model

YUAN Dou, TAN Chen, YAO Jian-min, LI Dan, HUANG Si-hui, WU Zhong

Abstract

 This study was aimed to assess mechanisms underlying continuous training induced atrial fibrillation (AF) in an animal model.  Methods  Healthy New Zealand rabbits were divided into three groups (n=12 each): control group (C), moderate intensity group (M), and high intensity group (H). The intensity of continuous training was adjusted according to the treadmill speed. After 12 weeks of training, with a Langendorff perfusion system, AF was induced by S1S2 stimulation and the incidence was recorded. Changes in atrial kir2.1, kir2.2, type Ⅰ and Ⅲ collagen protein mRNA expressions were assessed by quantitative real-time PCR. Masson staining was used to assess the extracellular collagen volume fraction (CVF) .  Results  After 12 weeks, comparing with group C, groups M and H had greater (P<0.05): CVF, incidence of AF (P<0.05, also between Groups H and M), and atrial inward rectifier potassium current/channel (IK1) . In Group H, kir2.1, kir2.2, type Ⅰ and Ⅲ collagen protein mRNA expressions in the left atrium were increased (P<0.05, compared with Groups C and M).  Conclusion   Long-term and high-intensity treadmill running could increase AF incidence in rabbits.

 

Keywords: Atrial fibrillation, Endurance exercise, IK1, Collagen

 

Full Text:

PDF


References


RAHMAN F， KWAN G F， BENJAMIN E J， et al. Global epidemiology of atrial fibrillation. Nat Rev Cardiol，2016，13(8): 501.

PIERONI M， DELLO RUSSO A， MARZO F， et al. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol，2009，53(8): 681–689.

CALVO N， BRUGADA J， SITGES M， et al. Atrial fibrillation and atrial flutter in athletes. Br J Sports Med，2012，46(1): 137–143.

ELOSUA R， ARQUER A， MONT L， et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol，2006，108(3): 332–337.

MONT L， SAMBOLA A， BRUGADA J， et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J，2002，23(6): 477–482.

GABORIT N， STEENMAN M， LAMIRAULT G， et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation，2005， 112(4): 471–481.

MIRAGOLI M， GLUKHOV A V. Atrial fibrillation and fibrosis: beyond the cardiomyocyte centric view. Biomed Res Int，2015，2015: 798768[2019-04-18].https://doi.org/10.1155/2015/798768.

SCHNABEL R B， SULLIVAN L M， LEVY D， et al. Development of a risk score for atrial fibrillation (framingham heart study): a community-based cohort study. Lancet，2009，373(9665): 739–745.

YUAN W， GINSBURG K S， BERS D M， et al. Comparison of sarcolemmal calcium channel current in rabbit and rat ventricular myocytes. J Physiol，1996，493(Pt3): 733–746.

BEDFORD T G， TIPTON C M， WILSON N C， et al. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol，1979，47(6): 1278–1283.

GAUSTAD S E， ROLIM N， WISLOFF U， et al. A valid and reproducible protocol for testing maximal oxygen uptake in rabbits. Eur J Cardiovasc Prev Rehabil，2010，17(1): 83–88.

SISCOVICK D S， WEISS N S， FLETCHER R H， et al. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med，1984， 311(14): 874–877.

REDOATH C J， BACKX P H. Atrial fibrillation and the athletic heart. Curr Opin Cardiol，2015，30(1): 17–23.

TURAGAM M K， VELAGAPUDI P， KOCHERIL A G， et al. Atrial fibrillation in athletes. Am J Cardiol，2012，109(2): 296–302.

SIEGEL A J， STEC J J， LIPINSKA I， et al. Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol，2001，88(8): 918–920.

SWANSON D R. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses，2006，66(6): 1085–1092.

BENITO B， GAY-JORDI G， SERRANO-MOLLAR A， et al. cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation，2011，123(1): 13–22.

SCHRAM G， POURRIER M， WANG Z， et al. Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents. Cardiovasc Res，2003，59(2): 328–338.

ZOBEL C， CHO H C， NGUYEN T T， et al. Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric coassembly of Kir2.1 and Kir2.2. Physiol，2003， 550(2): 365–372.

DHAMOON A S， PANDIT S V， SARMAST F， et al. Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K+ current. Circ Res，2004，94(10): 1332–1339.

LOPATIN A N， NICHLOS C G. Inward rectifiers in the heart: an update on IK1. J Mol Cell Cardiol，2001，33(4): 625–638.

SAYGILI E， RANA O R. Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes. Am J Physiol Heart Circ Physiol，2007，292(6): H2898–H2905.

DOBREV D， WETTER E， KORTNER A， et al. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res，2002，54(2): 397–404.

ZITRON E， KIESECKER C， LÜCK S， et al. Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A. Cardiovasc Res，2004，63(3): 520–527.

SCHERER D， KIESECKER C， KULZER M， et al. Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2. Naunyn Schmiedebergs Arch Pharmacol， 2007，375(5): 311–322.

KARSCHIN A. Gprotein regulation of inwardly rectifying K+ channels. News Physiol Sci，1999，14: 215–220.

PELLICIA A， MARON B J， DI PAOLO F M， et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol，2005，46(4): 690–696.

SWANSON D R. Running, esophageal acid reflux and atrial fibrillation: a chain of events linked by evidence from separate medical literatures. Med Hypotheses，2008，71(2): 178–185.

LEASK A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res，2015，116(7): 1269–1276.

WWANG B， TEDDER M E， PEREZ C E， et al. Structural and biomechanical characterizations of porcine myocardial extracellular matrix. J Mater Sci Mater Med，2012，23(8): 1835–1847.

MIZUNO T， YAU T M， WEISEL R D， et al. Elastin stabilizes an infarct and preserves ventricular function. Circulation，2005，112(9 suppl): 181–188.

KAWAMURA M， MUNETSUGU Y， KAWASAKI S， et al. Type Ⅲ procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion. Europace，2012，14(12): 1719–1725.

WANG X， LI Y， LIU L， et al. The role of matrix metalloproteinase-2 in the treatment of atrial fibrillation recurrence after a radiofrequency modified maze procedure. Cardiology，2013，126(1): 62–68.

ZHANG Y J， MA N， SU F， et al. Increased TRPM6 expression in atrial fibrillation patients contribute to atrial fibrosis. Exp Mol Pathol，2015， 98(3): 486–490.

ZHU D， WU Z， VANDER GEEST R J， et al. Accuracy of late gadolinium enhancement - magnetic resonance imaging in the measurement of left atrial substrate remodeling in patients with rheumatic mitral valve disease and persistent atrial fibrillation. Int Heart J，2015，56(5): 505–510.

JALIFE J， KAUR K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med，2015，25(6): 475–484.

BEGG G A， HOLDEN A V， LIP G Y， et al. Assessment of atrial fibrosis for the rhythm control of atrial fibrillation. Int J Cardiol，2016，220: 155–161.


Refbacks

  • There are currently no refbacks.